Skip to content
Shameless Cloning

Search Shameless Cloning

Search superinvestors, stocks, insiders and members of Congress

Q2 2026 · SEC CIK 0001314620

Hillman Capital Management portfolio

SuperinvestorAsset managerHillman Capital Management, Inc. filed on 2026-08-14. Open SEC filings ↗

Reported 13F value
$138.2M
Reported positions
54
Eligible equities
51
Holdings vs S&P 500, 3 years
-7.5 pts

Average holding period of the top positions: 4.4 yrs. Holdings vs the S&P 500 over 1 and 5 years: +0.6 pts, -5.4 pts.

In its Q2 2026 13F, filed 2026-08-14, Hillman Capital Management, Inc. reported 54 positions worth $138.2M. Its largest holdings were CVS HEALTH CORP (CVS, 4.2%), BIOGEN INC (BIIB, 3.8%), DUPONT DE NEMOURS INC (DD, 3.7%). Over the last 3 years its top holdings ran 7.5 points a year behind the S&P 500.

Reported holdings in the Q2 2026 13F.

The portfolio weight uses the full reported share-portfolio denominator. Weight changes compare this 13F with the one before it; price moves also change weights, so these are not trade labels. “New” means the position was not in the previous 13F at all; “—” marks a small position the earlier filing data does not cover.

Hillman Capital Management eligible holdings
Stock% of reported portfolioWeight changeReported value
CVSCVS HEALTH CORP4.2%+0.79 pp$5.7M
BIIBBIOGEN INC3.8%-0.01 pp$5.2M
DDDUPONT DE NEMOURS INC3.7%—$5.1M
WBDWARNER BROS DISCOVERY INC3.7%-0.08 pp$5.1M
BAXBAXTER INTL INC3.6%+0.76 pp$5.0M
IFFINTERNATIONAL FLAVORS&FRAGRA3.6%-0.06 pp$5.0M
GSKGSK PLC3.5%-0.23 pp$4.8M
KMXCARMAX INC3.5%+0.35 pp$4.8M
BABOEING CO3.4%+0.29 pp$4.7M
ZBHZIMMER BIOMET HOLDINGS INC3.4%-0.14 pp$4.6M
KHCKRAFT HEINZ CO3.4%+0.22 pp$4.6M
BF-BBROWN FORMAN CORP3.3%+0.09 pp$4.6M
PFEPFIZER INC3.0%-0.62 pp$4.2M
ELLAUDER ESTEE COS INC2.9%+0.27 pp$4.0M
FISVFISERV INC2.8%-0.34 pp$3.8M
MSFTMICROSOFT CORP2.8%-0.00 pp$3.8M
CPBTHE CAMPBELLS COMPANY2.6%+0.03 pp$3.6M
ADBEADOBE INC2.6%-0.17 pp$3.5M
NKENIKE INC2.3%-0.53 pp$3.2M
TSMTAIWAN SEMICONDUCTOR MANUFAC1.9%+0.07 pp$2.7M
BMYBRISTOL-MYERS SQUIBB CO1.9%-0.35 pp$2.6M
WSTWEST PHARMACEUTICAL SVSC INC1.8%+0.30 pp$2.6M
USBUS BANCORP1.8%-0.09 pp$2.5M
VEEVVEEVA SYS INC1.8%—$2.5M
CMCSACOMCAST CORP NEW1.8%-0.11 pp$2.5M
DISDISNEY WALT CO1.8%+0.12 pp$2.4M
CAGCONAGRA BRANDS INC1.8%+0.15 pp$2.4M
VZVERIZON COMMUNICATIONS INC1.8%-0.51 pp$2.4M
UPSUNITED PARCEL SVCS INC1.7%+0.21 pp$2.4M
BDXBECTON DICKINSON & CO1.7%+0.12 pp$2.3M
UNHUNITEDHEALTH GROUP INC1.6%+0.23 pp$2.2M
DEODIAGEO PLC1.6%+0.18 pp$2.2M
STZCONSTELLATION BRANDS INC1.6%-0.38 pp$2.2M
CRMSALESFORCE INC1.5%+0.13 pp$2.1M
EFXEQUIFAX INC1.4%-0.25 pp$2.0M
AKAMAKAMAI TECHNOLOGIES INC1.4%-0.42 pp$1.9M
HSYHERSHEY CO1.3%-0.18 pp$1.9M
ORCLORACLE CORP1.2%-0.43 pp$1.7M
MDTMEDTRONIC PLC0.3%+0.10 pp$446K
TROWPRICE T ROWE GROUP INC0.3%-1.32 pp$410K
APDAIR PRODUCTS AND CHEMICALS I0.3%+0.01 pp$383K
ACNACCENTURE PLC IRELAND0.3%—$380K
TMOTHERMO FISHER SCIENTIFIC INC0.3%+0.05 pp$376K
RTXRTX CORPORATION0.3%+0.00 pp$367K
GOOGALPHABET INC0.3%+0.04 pp$364K
NOWSERVICENOW INC0.2%+0.00 pp$339K
CLXCLOROX CO DEL0.2%-0.01 pp$337K
BLKBLACKROCK INC0.2%+0.01 pp$330K
INTUINTUIT0.2%-0.06 pp$314K
CSGPCOSTAR GROUP INC0.2%-0.02 pp$304K
GOOGLALPHABET INC0.0%+0.00 pp$1K

What Hillman Capital Management bought and sold in Q2 2026, against Q1 2026.

New positions

Q1 2026's filing was too long to tell new positions apart.

Share counts compared with the Q1 2026 13F; a split also changes share counts. The latest filing lists more than 50 positions, so a position that left the top 50 may still be held.

How the holdings did against the S&P 500.

1 year
+19.2% /yr
S&P 500 +20.1%
3 years
+11.4% /yr
S&P 500 +20.4%
5 years
+5.7% /yr
S&P 500 +11.6%

A portfolio of the filer's 20 largest 13F positions, weighted by value and rebuilt each quarter on the day the filing became public. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.

Questions about Hillman Capital Management's portfolio

What stocks does Hillman Capital Management own?

Hillman Capital Management, Inc.'s latest 13F, for Q2 2026 and filed Aug 14, 2026, lists 54 positions worth $138.2M. The largest are Cvs Caremark Corporation (CVS) at 4.2%, Biogen Inc (BIIB) at 3.8%, Dupont de Nemours Inc (DD) at 3.7%, Warner Bros Discovery Inc (WBD) at 3.7% and Baxter Intl Inc (BAX) at 3.6%.

What did Hillman Capital Management buy last quarter?

In Q2 2026, Hillman Capital Management, Inc. added Ishares Core S&p 500 ETF (IVV) (+27.1% shares), Salesforce Inc Com (CRM) (+24.7% shares) and Conagra Brands Inc (CAG) (+22.4% shares), compared with its Q1 2026 filing.

What did Hillman Capital Management sell last quarter?

In Q2 2026, Hillman Capital Management, Inc. cut from its top 50 Dupont de Nemours (DD), cut from its top 50 Intuit (INTU), cut from its top 50 Ge Aerospace (GE), cut from its top 50 Costar Group Inc (CSGP), cut from its top 50 Spdr Series Trust (SPLG), T. Rowe Price Group Inc. (TROW) (-86.1% shares), Taiwan Semiconductor Manufac (TSM) (-29.6% shares) and Oracle Corp (ORCL) (-28.6% shares), compared with its Q1 2026 filing.

How has Hillman Capital Management's portfolio performed?

A portfolio copying Hillman Capital Management, Inc.'s 20 largest 13F holdings each quarter, from the day each filing was public, returned +11.4% a year over the last 3 years, against +20.4% for the S&P 500. Over 1 year: +19.2% against +20.1%. Over 5 years: +5.7% a year against +11.6%.

When is Hillman Capital Management, Inc.'s next 13F filing due?

13F filings are due 45 days after each quarter ends. Hillman Capital Management, Inc.'s filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.

How much money does Hillman Capital Management, Inc. manage?

Hillman Capital Management, Inc. reported $195.9M of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $138.2M.